Apomorphine pharmacokinetic-pharmacodynamic correlations following single and repeated subcutaneous injections in patients with Parkinson's disease

被引：0
|
作者：
Bottini, PB
Shaw, A
Huang, MY
Sherry, JH
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P293
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats
    Bhardwaj, Pallavi
    Sidhu, Pritam K.
    Lonare, M. K.
    Kaur, Rajdeep
    Dumka, V. K.
    Rampal, S.
    RESEARCH IN VETERINARY SCIENCE, 2018, 121 : 111 - 115
  • [22] Pharmacokinetic-pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects
    Aymard, G
    Berlin, I
    de Brettes, B
    Diquet, B
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (04) : 473 - 481
  • [23] The tolerability of intermittent subcutaneous apomorphine in patients with advanced Parkinson's disease
    Koller, D
    Pahwa, D
    MOVEMENT DISORDERS, 2004, 19 : S203 - S203
  • [24] Electrocardiographic assessment of subcutaneous apomorphine in patients with advanced Parkinson's disease
    Sherry, JH
    Bottini, PB
    Burkhart, GA
    MOVEMENT DISORDERS, 2005, 20 : S144 - S144
  • [25] Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease
    Gobburu, JVS
    Tammara, V
    Lesko, L
    Jhee, SS
    Sramek, JJ
    Cutler, NR
    Yuan, RH
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (10): : 1082 - 1090
  • [26] An evaluation of subcutaneous apomorphine for the treatment of Parkinson's disease
    Mueller, Thomas
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (14) : 1659 - 1665
  • [27] Intermittent subcutaneous apomorphine in advanced Parkinson's disease
    Storch, A
    PSYCHOPHARMAKOTHERAPIE, 2005, 12 (01): : 17 - 22
  • [28] The role of subcutaneous infusion of apomorphine in Parkinson's disease
    Wenzel, Karoline
    Homann, Carl Nikolaus
    Fabbrini, Giovanni
    Colosimo, Carlo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (07) : 833 - 843
  • [29] Continuous subcutaneous apomorphine monotherapy in Parkinson's disease
    Papuc, Ewa
    Trzciniecka, Olga
    Rejdak, Konrad
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2019, 26 (01) : 133 - 137
  • [30] Intermittent subcutaneous apomorphine therapy in Parkinson's disease
    Factor, SA
    NEUROLOGY, 2004, 62 (06) : S12 - S17
12345